2Kayasilcuk F,Zorludemir S,Gumurduhu D,et al.PCNA and Ki-67 in central nervous system tumors:correlation with the histological type and grade.J Neurooncol,2002,57(2):115-121.
3Enestrom S,Vavruch L,Franlund B,et al.Ki-67 antigen expression as a prognostic factor in primary and recurrent astrocytomas.Neurochirurgie,1998,44(1):25-30.
2[1]Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990; 174:411 ～ 415
3[3]Walker DG, Duan W, Popvic EA, et al. Homozygous deletions of the multiple tumour suppressor gene 16 in the progression of human astrocytomas. Cancer Res 1995; 55:20
4[4]Jaros E, Perry RH, Adam L, et al. Prognostic implications of p53protein, epidermal growth factor receptor, and Ki- 67 labeling in brain tumors. Br J Cancer 1992; 66: 373～ 376
5[5]Weinder K, Mornglane JR, Marme D, et al. Detection and quantification of vascular endothelial growth factor/ vascular permeability factor in brain tumor tissue and cyst fluid: the key to angiogenesis. Neurosurgery 1994; 35:439 ～ 447
6[7]Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 1992; 34:463 ～ 469
7R. Schr?der,K. Bien,R. Kott,I. Meyers,R. V?ssing. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time[J] 1991,Acta Neuropathologica(5):389～394
